(Q72533994)
Statements
[A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer] (English)
Y Sakata
Y Shimada
M Yoshino
M Kambe
K Futatsuki
I Nakao
N Ogawa
A Wakui